AT1 FY21 - General Discussion + FA, page-15

The core value I see from AT1 is it is an enabling device for many tests where the hard work of clinical development is done by other customers and Atomo can pick and choose from the best the add value and leverage the value intrinsic to the test without the same level of capital investment.
Think of a gold refiner servicing miners. Simbiotic with less risk. Added to the margins n this sector and it seems a winning core value proposition.
I think as sales are done the value will be recognized and re-rate accordingly.

GLTAH.